ArticleNature cancer2023
Author Correction: An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia.
Abstract readPublished Erratum
In one paragraph
Article in Nature cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia.HemaSphere · 2026Article
- Overcoming resistance to immune checkpoint inhibitor therapy in acute myeloid leukemia.Frontiers in oncology · 2026Review
- RNA binding of GAPDH controls transcript stability and protein translation in acute myeloid leukemia.RNA biology · 2025Article
- Article
- Development of multivalent CAR T cells as dual immunotherapy and conditioning agents.Molecular therapy. Oncology · 2025Article
- Advancing drug development in myelodysplastic syndromes.Blood advances · 2025Review
- DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome.Frontiers in cell and developmental biology · 2025Review
- CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia.Blood · 2024Article
- The never-abating excitement for targeted therapies.Nature cancer · 2023Article
Corrections and comments
- Erratum for
Authors and funding
22 authors.
Audrey Lasry *Department of Pathology, New York University School of Medicine, New York, NY, USA.
Bettina Nadorp *Department of Pathology, New York University School of Medicine, New York, NY, USA.
Maarten FornerodDepartment of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-6166-3030
Deedra NicoletThe Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
Huiyun WuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Christopher J WalkerThe Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA.
Zhengxi SunDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Matthew T WitkowskiDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-1434-4288
Anastasia N TikhonovaDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-6712-1606
Maria Guillamot-RuanoDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Geraldine CayananDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Anna YeatonDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Gabriel RobbinsDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-4447-0667
Esther A ObengDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-8691-7439
Aristotelis TsirigosDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-7512-8477
Richard M StoneDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
John C ByrdDepartment of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.
Stanley PoundsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-9167-2114
William L CarrollDepartment of Pathology, New York University School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-1550-4167
Tanja A GruberDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. tagruber@stanford.edu.ORCID http://orcid.org/0000-0003-1072-7257
Ann-Kathrin EisfeldThe Ohio State University Comprehensive Cancer Center, Clara D. Bloomfield Center for Leukemia Outcomes Research, Columbus, OH, USA. ann-kathrin.eisfeld@osumc.edu.ORCID http://orcid.org/0000-0001-6442-1419
Iannis AifantisDepartment of Pathology, New York University School of Medicine, New York, NY, USA. ioannis.aifantis@nyulangone.org.ORCID http://orcid.org/0000-0001-6857-1035
Funding
Role of TET2 mutations in malignant transformation and acute myeloid leukemiaR01CA173636 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AIFANTIS, IANNIS, LEVINE, ROSS L · 2013 to 2022
$6.3MDissecting innate immune signaling in pre-leukemia evolutionR01CA271455 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI Iannis Aifantis, Daniel Starczynowski · 2022 to 2026
$3.2MTargeting an RNA Binding Protein Network in Acute Myeloid LeukemiaR01CA242020 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ABDEL-WAHAB, OMAR, AIFANTIS, IANNIS · 2020 to 2024
$2.7MRegulation of emergency hematopoiesis by the ubiquitin-proteasome systemR01HL159175 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI AIFANTIS, IANNIS, BUSINO, LUCA · 2021 to 2024
$2.5MMechanisms of enhancer regulation in leukemiaR01CA228135 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AIFANTIS, IANNIS · 2019 to 2023
$2.5MNCI NIH HHS R01 CA173636U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1R01CA228135U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA242020U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA271455U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 1R01HL159175
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
36658429What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.